The Changing Landscape of Heart Failure Drug Clinical Trials in China, 2013–2023
用户qF7pME5zq23w
1小时前
27
10
已关闭
DOI:
文献链接:
其他信息:
W Zhang, Y Zhang, J Tang, X Wang…
Drug Design …, 2025
Taylor & Francis
… Chinese pharmaceutical enterprises have also developed the highly potent and selective
phosphodiesterase 9 (PDE9) inhibitor TT-00920 and the diuretic HRS-9057, both of which …

